Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
NCT03653364
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
DRUG:
Baloxavir Marboxil
Sponsor
Hoffmann-La Roche